0001656472-23-000153.txt : 20231215
0001656472-23-000153.hdr.sgml : 20231215
20231215171206
ACCESSION NUMBER: 0001656472-23-000153
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230512
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weigensberg Arye
CENTRAL INDEX KEY: 0001937121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 231491312
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: MV5 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wk-form4_1702678313.xml
FORM 4
X0508
4
2023-05-12
0
0001656472
Cronos Group Inc.
CRON
0001937121
Weigensberg Arye
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
0
1
0
0
See Remarks
0
COMMON SHARES
2023-05-12
4
M
0
9012
0
A
16049
D
COMMON SHARES
2023-05-25
4
M
0
3972
0
A
20021
D
COMMON SHARES
2023-12-13
4
M
0
6421
0
A
26442
D
RESTRICTED STOCK UNITS
2023-05-12
4
M
0
9012
0
D
COMMON SHARES
9012
119479
D
RESTRICTED STOCK UNITS
2023-05-25
4
M
0
3972
0
D
COMMON SHARES
3972
115507
D
RESTRICTED STOCK UNITS
2023-12-13
4
M
0
6421
0
D
COMMON SHARES
6421
109086
D
Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
On May 12, 2022, the reporting person was granted 27,040 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On May 25, 2021, the reporting person was granted 11,917 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On December 13, 2022, the reporting person was granted 19,266 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Senior Vice President, Head of Research and Development
/s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg
2023-12-15